RNAC
Cartesian Therapeutics Inc.
7.60$
-3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.27 | 1.60 | 1.08 | 1.88 | 0.02 | -0.03 | 0.04 | 0.01 | 0.02 | 0.04 | 0.00 | 0.00 | 0.05 | |
| 2.52 | 0.02 | 0.03 | 0.01 | 0.01 | – | – | – | 0.49 | – | – | – | – | |
| -1.25 | 1.60 | 1.08 | 1.88 | 0.02 | -0.03 | 0.04 | 0.01 | -0.47 | 0.04 | 0.00 | – | – | |
| 2.52 | 4.34 | 1.80 | 0.71 | 0.53 | 0.44 | 0.57 | 0.56 | 0.53 | 0.57 | 0.72 | 0.68 | 2.29 | |
| 1.09 | 4.29 | 1.75 | 0.39 | 0.31 | 0.27 | 0.32 | 0.27 | 0.25 | 0.32 | 0.26 | 0.29 | 1.03 | |
| 1.28 | 8.63 | 3.54 | 1.11 | 0.84 | 1.00 | 0.89 | 0.84 | 0.34 | 0.88 | 0.99 | 0.98 | 2.92 | |
| -2.53 | -7.03 | -2.47 | 0.77 | -0.82 | -1.03 | -0.85 | -0.82 | -0.81 | -0.84 | -0.99 | -0.98 | -3.30 | |
| 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | – | 0.03 | – | |
| -1.74 | -38.04 | -10.50 | 0.78 | -1.13 | -0.38 | -0.68 | 0.60 | -1.38 | -3.92 | -1.46 | 0.53 | -5.39 | |
| 0.30 | -3.67 | 0.03 | 0.01 | – | 0.01 | – | – | – | -0.35 | – | – | – | |
| -1.74 | -34.36 | -10.50 | 0.78 | -1.13 | -0.40 | -0.68 | 0.60 | -1.38 | -3.56 | -1.46 | 0.46 | -5.16 | |
| -1.46 | -37.98 | -10.46 | 0.79 | -1.11 | -0.37 | -0.64 | 0.62 | -1.36 | -3.89 | -1.44 | 0.58 | -5.28 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.